Four Threats to DSO Growth in 2026: Supply, Rates, Oversight, and Medicaid Cuts
Turn adjusted EBITDA and a few practice details into a directional enterprise-value range with our Healthcare Practice Valuation Calculator. Educational and directional, and no email required.
May 12, 2026
Four structural headwinds are challenging DSO acquisition plans in 2026: low practice supply, elevated interest rates, mounting state legislative oversight, and projected federal Medicaid cuts of $664 billion through 2034. With 69% of DSOs targeting acquisition growth but fewer available practices, TUSK Practice Sales warns the market has shifted to high-demand, low-supply conditions — forcing DSOs to apply greater scrutiny to deal financials and performance projections. In Kentucky and Illinois, new legislation is actively restricting corporate control of clinical dental decisions. Meanwhile, the One Big Beautiful Bill’s Medicaid reductions create downstream volume risk for the many DSOs that serve adult and child Medicaid populations, a segment representing significant revenue at groups operating in lower-income markets.
DSO operators and PE sponsors modeling growth need to account for all four headwinds, not just cost of capital. Practice supply constraints and state-level regulatory risk are underappreciated structural challenges that could compress deal timelines and return expectations through the back half of 2026 and into 2027.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.
What are the biggest structural threats to DSO acquisition growth in 2026?
Four headwinds are converging: a constrained supply of available practices with 69 percent of DSOs competing for fewer assets, elevated interest rates compressing deal returns, new state legislation in Kentucky and Illinois restricting DSO operational structures, and projected federal Medicaid cuts of $664 billion through 2034 that threaten reimbursement-dependent patient revenue.
How are projected Medicaid cuts expected to affect dental groups?
Federal Medicaid cuts of $664 billion through 2034 would reduce reimbursement for Medicaid-dependent patient populations, particularly in community health and safety-net settings. DSOs with heavy Medicaid exposure should model downside revenue scenarios and evaluate payer mix diversification to reduce concentration risk.
Why is the supply of practices available for DSO acquisition declining?
TUSK Practice Sales reports a high-demand, low-supply dynamic driven by strong DSO appetite and a shrinking seller pool. Younger dentists increasingly enter employment or partnership rather than ownership — reducing future inventory — while owners who do sell attract multiple bidders, pushing valuations and deal scrutiny higher.